Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Eli Lilly and Company Limited
Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL
Telephone: +44 (0)1256 315 000
Fax: +44 (0)1256 775 858
WWW: http://www.lilly.co.uk
Medical Information e-mail: ukmedinfo@lilly.com
Medical Information Fax: +44 (0)1256 775 569

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 30/03/2012
PIL Byetta 5 micrograms solution for injection, prefilled pen. Byetta 10 micrograms solution for injection, prefilled pen.

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 30/03/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to information about driving or using machinery
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 30/09/2011 and displayed until 30/03/2012
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
Updated on 27/09/2010 and displayed until 30/09/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to manufacturer contact details
Updated on 07/06/2010 and displayed until 27/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 19/03/2009 and displayed until 07/06/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 28/10/2008 and displayed until 19/03/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 29/04/2008 and displayed until 28/10/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 18/02/2008 and displayed until 29/04/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 09/01/2008 and displayed until 18/02/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change to date of revision
Updated on 10/09/2007 and displayed until 09/01/2008
Reasons for adding or updating:
  • Change to storage instructions
  • Change to date of revision
Updated on 02/01/2007 and displayed until 10/09/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  exenatide